PLRX Covered Call Strategy
PLRX (Pliant Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Pliant Therapeutics, Inc. is a biopharmaceutical company in the clinical development stage, dedicated to discovering, advancing, and bringing to market innovative therapies for fibrotic and related diseases across the United States. Its flagship investigational product, PLN-74809, is an orally administered, small-molecule, dual-selective inhibitor targeting both avß6 and avß1 integrins, which is currently progressing through three distinct Phase 2a clinical trials. The company's pipeline also includes PLN-1474, a small-molecule selective inhibitor of avß1, which has successfully completed its Phase 1 clinical assessment for treating liver fibrosis associated with nonalcoholic steatohepatitis (NASH). Furthermore, Pliant is nurturing two additional integrin-based initiatives in preclinical development: one focused on oncology, and another involving an allosteric agonistic monoclonal antibody designed to act upon an undisclosed integrin receptor for the treatment of various muscular dystrophies, including Duchenne muscular dystrophy. Founded in 2015, Pliant Therapeutics, Inc. maintains its corporate headquarters in South San Francisco, California.
PLRX (Pliant Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $66.3M, a beta of 1.25 versus the broader market, a 52-week range of 1.02-1.95, average daily share volume of 504K, a public-listing history dating back to 2020, approximately 49 full-time employees. These structural characteristics shape how PLRX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.25 places PLRX roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a covered call on PLRX?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
PLRX snapshot
As of August 14, 2026, spot at $1.08, ATM IV 21.20%, IV rank 0.37%, expected move 6.08%. The covered call on PLRX below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this covered call structure on PLRX specifically: PLRX IV at 21.20% is on the cheap side of its 1-year range, which means a premium-selling PLRX covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 6.08% (roughly $0.07 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated PLRX expiries trade a higher absolute premium for lower per-day decay. Position sizing on PLRX should anchor to the underlying notional of $1.08 per share and to the trader's directional view on PLRX stock.
PLRX covered call setup
The PLRX covered call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With PLRX at $1.08 on that close, the first option leg uses a $1.13 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed PLRX chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 PLRX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $1.08 | long |
| Sell 1 | Call | $1.13 | N/A |
PLRX covered call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
PLRX covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on PLRX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use covered call on PLRX
Covered calls on PLRX are an income strategy run on existing PLRX stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
PLRX thesis for this covered call
The market-implied 1-standard-deviation range for PLRX extends from approximately $1.01 on the downside to $1.15 on the upside. A PLRX covered call collects premium on an existing long PLRX position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether PLRX will breach that level within the expiration window. Current PLRX IV rank near 0.37% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on PLRX at 21.20%. As a Healthcare name, PLRX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to PLRX-specific events.
PLRX covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. PLRX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move PLRX alongside the broader basket even when PLRX-specific fundamentals are unchanged. Short-premium structures like a covered call on PLRX carry tail risk when realized volatility exceeds the implied move; review historical PLRX earnings reactions and macro stress periods before sizing. Always rebuild the position from current PLRX chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on PLRX?
- A covered call on PLRX is the covered call strategy applied to PLRX (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With PLRX stock at $1.08 on the most recent close, the strikes shown on this page are snapped to the nearest listed PLRX chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are PLRX covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the PLRX covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 21.20%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a PLRX covered call?
- The breakeven for the PLRX covered call priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The PLRX market-implied 1-standard-deviation expected move in the same options snapshot is approximately 6.08%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on PLRX?
- Covered calls on PLRX are an income strategy run on existing PLRX stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current PLRX implied volatility affect this covered call?
- PLRX ATM IV is at 21.20% with IV rank near 0.37%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.